About Neuronoff
Neuronoff is a company based in Santa Clarita (United States) founded in 2013 by Andrew Shoffstall and Manfred Franke.. Neuronoff has raised $4.5 million across 4 funding rounds from investors including NIH, HHS and U.S. Department of Defense. The company has 21 employees as of December 31, 2024. Neuronoff offers products and services including Injectrode and External Pulse Generator. Neuronoff operates in a competitive market with competitors including ONWARD, Nalu Medical, Atlantic Therapeutics, Synchron and SpineX, among others.
- Headquarter Santa Clarita, United States
- Employees 21 as on 31 Dec, 2024
- Founders Andrew Shoffstall, Manfred Franke
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Neuronoff, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.5 M (USD)
in 4 rounds
-
Latest Funding Round
$4.5 M (USD), Series A
Oct 08, 2025
-
Investors
NIH
& 2 more
-
Employee Count
21
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Neuronoff
Neuronoff offers a comprehensive portfolio of products and services, including Injectrode and External Pulse Generator. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Needle-based system for neuromodulation to alleviate chronic pain signals.
Delivers electrical signals through skin to modulate nerve pain effectively.
Funding Insights of Neuronoff
Neuronoff has successfully raised a total of $4.5M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $4.5 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $4.5M
-
First Round
First Round
(04 Nov 2019)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2025 | Amount | Series A - Neuronoff | Valuation |
investors |
|
| Jan, 2025 | Amount | Grant - Neuronoff | Valuation |
investors |
|
| Aug, 2023 | Amount | Grant - Neuronoff | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Neuronoff
Neuronoff has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include NIH, HHS and U.S. Department of Defense. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location | |
|
Military forces are provided by the U.S. Department of Defense for national security.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Neuronoff
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Neuronoff
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Neuronoff Comparisons
Competitors of Neuronoff
Neuronoff operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ONWARD, Nalu Medical, Atlantic Therapeutics, Synchron and SpineX, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutic devices for spinal cord injuries are developed and delivered.
|
|
| domain | founded_year | HQ Location |
Developer of a neurostimulation system for managing intractable chronic pain
|
|
| domain | founded_year | HQ Location |
Non-invasive wearable devices for pelvic floor strengthening are developed.
|
|
| domain | founded_year | HQ Location |
Implantable bioelectronics are developed for neurological condition treatments.
|
|
| domain | founded_year | HQ Location |
Neuromodulation devices for neurological disorders are developed and offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Neuronoff
Frequently Asked Questions about Neuronoff
When was Neuronoff founded?
Neuronoff was founded in 2013 and raised its 1st funding round 6 years after it was founded.
Where is Neuronoff located?
Neuronoff is headquartered in Santa Clarita, United States. It is registered at Santa Clarita, California, United States.
Who is the current CEO of Neuronoff?
Manfred Franke is the current CEO of Neuronoff. They have also founded this company.
Is Neuronoff a funded company?
Neuronoff is a funded company, having raised a total of $4.5M across 4 funding rounds to date. The company's 1st funding round was a Grant of $596.58K, raised on Nov 04, 2019.
How many employees does Neuronoff have?
As of Dec 31, 2024, the latest employee count at Neuronoff is 21.
What does Neuronoff do?
Developer of a neuromodulation device to restore and improve organ activity. The device Injectrod is a novel injectable metal electrode that is deployed via a small needle for manufacturing the neuromodulation interface inside the body on a variety of anatomical targets. It is an alternative means of treating chronic back pain.
Who are the top competitors of Neuronoff?
Neuronoff's top competitors include ONWARD, Synchron and Nalu Medical.
What products or services does Neuronoff offer?
Neuronoff offers Injectrode and External Pulse Generator.
Who are Neuronoff's investors?
Neuronoff has 3 investors. Key investors include NIH, HHS, and U.S. Department of Defense.